Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6028171
Class I MHC modulation of surface receptor activity
expired patentUS 6027737
Treatment for osteoporosis using potassium salts
expired patentUS 6025328
Antitumor agents
expired patentUS 6024936
Antibody-based method of localizing activated thrombin receptors
expired patentUS 6022854
Platelet specific therapeutic compound and method of treating
expired patentUS 6022697
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
expired patentUS 6020197
Method for production of neuroblasts
expired patentUS 6017714
Netrins
expired patentUS 6015659
Inducement of thermotolerance with benzoquinonoid ansamycins
expired patentUS 6015882
Vaccines, antibodies, proteins, glycoproteins, DNAs and RNAs for prophylaxis and treatment
expired patentUS 6015660
Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
expired patentUS 6015599
High vertical aspect ratio thin film structures
expired patentUS 6013781
Semaphorin gene family
expired patentUS 6013785
Polynucleoside chain having multiple ribonucleosides, the nucleosides coupled by guanidyl
expired patentUS 6013521
Method for production of neuroblasts
expired patentUS 6010846
Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
expired patentUS 6011139
Hybridomas and monoclonal antibodies that specifically bind to glutamic acid decarboxylase
expired patentUS 6011055
Treatment of cystic disease with compounds which stimulate TNF-.alpha. production in vivo
expired patentUS 6010908
Gene therapy by small fragment homologous replacement
expired patentUS 6010876
Clavanins
expired patentUS 6010691
Methods for enhancing permeation of a topically administered physiologically active substa
expired